General MedicationsORALGeneric
PREVACID
LANSOPRAZOLE
Standard Dose
15MG/PACKET
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview PREVACID is listed in Drugs@FDA under application 021281 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient LANSOPRAZOLE Form and strength FOR SUSPENSION, DELAYED RELEASE;ORAL - 15MG/PACKET Sponsor TAKEDA PHARMS NA Submission history Latest submission status date: 2009-07-31 00:00:00.
Structured Monograph
Clinical summary
Approval overview PREVACID is listed in Drugs@FDA under application 021281 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LANSOPRAZOLE Form and strength FOR SUSPENSION, DELAYED RELEASE;ORAL - 15MG/PACKET Sponsor TAKEDA PHARMS NA Submission history Latest submission status date: 2009-07-31 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.